...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure
【24h】

Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure

机译:断奶的免疫抑制独立于肾切除术,导致肾移植失败后晚期致敏

获取原文
获取原文并翻译 | 示例

摘要

Background: Patients returning to dialysis therapy after renal transplant failure have a high rate of human leukocyte antigen antibody sensitization, and sensitization has been linked to allograft nephrectomy. We hypothesized that nephrectomy for cause is a consequence of weaning immunosuppression and that weaning leads to sensitization even in the absence of nephrectomy. Methods: We examined outcomes in 300 consecutive patients with kidney allograft failure and survival of more than 30 days after failure. We analyzed a subset of 119 patients with a low panel reactive antibody (PRA) before transplantation and follow-up PRA testing at 6 to 24 months after failure (late PRA). Results: By late PRA testing, 56% of patients were highly sensitized (class I or II PRA 80%). On multivariate analysis controlling for human leukocyte antigen matching, allograft nephrectomy, and other variables, weaning of immunosuppression predicted high sensitization (odds ratio, 14.34; P=0.004). In a subset of patients, the percentage of those who were highly sensitized increased from 21% at the time of failure on immunosuppressive therapy to 68% by late PRA after weaning (P<0.001). Conversely, patients who maintained immunosuppression showed minimal sensitization after failure. Transplant nephrectomy was required in 41% of patients who weaned immunosuppression versus 0% of the 24 patients who maintained immunosuppression with calcineurin inhibitor therapy after failure (P<0.001). Conclusions: Weaning immunosuppression was a triggering event leading to late rejection and allograft nephrectomy and was an independent predictor of alloantibody sensitization after kidney allograft failure.
机译:背景:肾移植失败后返回透析治疗的患者对人类白细胞抗原抗体的致敏率很高,致敏作用与同种异体肾切除术有关。我们假设原因的肾切除术是断奶的免疫抑制的结果,即使没有肾切除术,断奶也会导致过敏。方法:我们检查了连续300例肾脏同种异体移植失败患者的结局,并分析了失败后30天以上的存活率。我们分析了119例移植前低反应性抗体(PRA)较低的患者的子集,并对失败后6至24个月的随访PRA测试(晚期PRA)进行了分析。结果:通过晚期PRA测试,有56%的患者高度敏感(I或II级PRA为80%)。在控制人白细胞抗原匹配,同种异体肾切除术和其他变量的多变量分析中,断奶的免疫抑制预示着高致敏性(优势比,14.34; P = 0.004)。在一部分患者中,高度敏感者的比例从免疫抑制治疗失败时的21%增加到断奶后晚期PRA的68%(P <0.001)。相反,维持免疫抑制的患者在失败后表现出最小的敏化作用。断奶的免疫抑制患者中有41%需要移植肾切除术,而钙调神经磷酸酶抑制剂治疗失败后仍保持免疫抑制的24例患者中,有0%需要进行移植肾切除术(P <0.001)。结论:断奶免疫抑制是导致晚期排斥反应和同种异体肾切除术的触发事件,并且是肾同种异体移植失败后同种抗体敏化的独立预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号